These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28137823)

  • 1. Topical tacrolimus solution in autoimmune polyglandular syndrome-1-associated keratitis.
    Shoughy SS; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1230-1233. PubMed ID: 28137823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Tacrolimus in Thygeson Superficial Punctate Keratitis.
    Shoughy SS; Tabbara KF
    Cornea; 2020 Jun; 39(6):742-744. PubMed ID: 31842035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Topical Tacrolimus in the Treatment of Thygeson's Superficial Punctate Keratitis.
    Marquezan MC; Nascimento H; Vieira LA; Serapião M; Ghanem RC; Belfort R; Freitas D
    Am J Ophthalmol; 2015 Oct; 160(4):663-8. PubMed ID: 26133248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical tacrolimus treatment for ocular cicatricial pemphigoid].
    Michel JL; Gain P
    Ann Dermatol Venereol; 2006 Feb; 133(2):161-4. PubMed ID: 16508602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study].
    Reinhard T; Reis A; Mayweg S; Oberhuber H; Mathis G; Sundmacher R
    Klin Monbl Augenheilkd; 2002 Mar; 219(3):125-31. PubMed ID: 11987039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine.
    Joko T; Shiraishi A; Ogata M; Ohashi Y
    J Nippon Med Sch; 2016; 83(1):31-4. PubMed ID: 26960587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus Eye Drops as Adjunct Therapy in Severe Corneal Endothelial Rejection Refractory to Corticosteroids.
    Ghaffari R; Ghassemi H; Zarei-Ghanavati M; Latifi G; Dehghani S; Haq Z; Djalilian AR
    Cornea; 2017 Oct; 36(10):1195-1199. PubMed ID: 28817391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual Photophobia in a Child.
    Osigian Probst CJ; Chang TC; Cavuoto KM
    JAMA Ophthalmol; 2016 Oct; 134(10):1195-1196. PubMed ID: 27490065
    [No Abstract]   [Full Text] [Related]  

  • 9. Thygeson's superficial punctate keratitis: ten years' experience.
    Nagra PK; Rapuano CJ; Cohen EJ; Laibson PR
    Ophthalmology; 2004 Jan; 111(1):34-7. PubMed ID: 14711711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratitis associated with multiple endocrine deficiency.
    Mohammadpour M; Javadi MA
    Cornea; 2006 Jan; 25(1):112-4. PubMed ID: 16331052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis.
    Merenmies L; Tarkkanen A
    Acta Ophthalmol Scand; 2000 Oct; 78(5):532-5. PubMed ID: 11037909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
    Jung JW; Lee YJ; Yoon SC; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2015 Mar; 159(3):519-27.e1. PubMed ID: 25498356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial.
    Müller EG; Santos MSD; Freitas D; Gomes JÁP; Belfort R
    Arq Bras Oftalmol; 2017 Jun; 80(3):154-158. PubMed ID: 28832739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety of treatment with tacrolimus ointment for anterior segment inflammatory diseases].
    Wyrsch S; Thiel MA; Becht CN
    Klin Monbl Augenheilkd; 2009 Apr; 226(4):234-6. PubMed ID: 19384773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Effect of Topical Tacrolimus Treatment on Herpetic Stromal Keratitis in a Rat Model.
    Eriş E; Yüksel N; Pirhan D; Karadenizli A; Aslan M; Gacar G; Erman G; Subaş C; Uzuner H; Yldz DK; Karaöz E
    Eye Contact Lens; 2016 May; 42(3):163-70. PubMed ID: 25996419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD; Goldman D; Ide T; Yoo SH
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases.
    Lee YJ; Kim SW; Seo KY
    Am J Ophthalmol; 2013 May; 155(5):804-13. PubMed ID: 23394907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.